Michael Burkes Brophy sold $1.2M of Natera (NTRA)

Executed Jan 27, disclosed Jan 29, 2 days later.

Value, as filed

$1.2M

5,064 sh across 5 lots

Executed

Jan 27

the trade date, as filed

Disclosed

Jan 29

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael Burkes Brophy CHIEF FINANCIAL OFFICER profile →

Michael Burkes Brophy (CHIEF FINANCIAL OFFICER) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Natera, Inc. (NTRA). The largest single filing was $14.6M of NTRA (61,123 sh across 3 lots, as filed), executed Jan 20.

The name

NTRA

Natera, Inc. NTRA · Healthcare · 219 filings in 24 months ticker →

Healthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael Burkes Brophy in NTRA

NTRASALE Natera, Inc. $131K
478 sh × $274.22
Exec Aug 4
Filed Aug 5 · 9:35 PM ET NTRASALE Natera, Inc. $1.2M
4,894 sh across 4 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET NTRASALE Natera, Inc. $101K
482 sh × $210.49
Exec May 4
Filed May 5 · 5:30 PM ET NTRASALE Natera, Inc. $809K
4,063 sh across 4 lots
Exec Apr 27
Filed Apr 29 · 5:30 PM ET NTRASALE Natera, Inc. $160K
785 sh × $204.13
Exec Mar 10
Filed Mar 11 · 5:30 PM ET NTRASALE Natera, Inc. $1.6M
6,939 sh across 3 lots
Exec Feb 3
Filed Feb 4 · 5:30 PM ET NTRASALE Natera, Inc. $14.6M
61,123 sh across 3 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET NTRASALE Natera, Inc. $623K
3,259 sh across 4 lots
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET